At Goodness Growth Holdings, we are determined to find better answers for the patients we serve. We are driven to keep the “medical” in medical cannabis by participating in establishing and applying evidence-based practices. We strive to guide our consumers and medical patients with honest and accurate information regarding therapeutic cannabis use and product safety. High-quality research is key in reaching these goals.
Most US states have now legalized some form of cannabis use. As a physician-led and founded company, we seek and support the guidance of scientists and clinicians. Currently, the U.S. federal government lists cannabis as a Schedule I Controlled Substance, meaning the federal government classifies it as having no accepted medical use and is unsafe to use even under medical supervision. These policies can stop the ability of clinicians, researchers, and patients to access the reliable information they need to stay informed on the benefits of medical cannabis and cannabis research.
We at Goodness Growth Holdings thank you for your interest and investment in medical cannabis research!Download PDF
Vireo Health is on the forefront of collaborative, high-fidelity research around scientifically accurate cannabis research.
Vireo Health’s leading scientific minds have been published in esteemed white papers and journals across the medical zeitgeist. Our goal is to educate and inspire new alternative medicines through legitimate scientific processes.